| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/23/2006 | US7049486 Plasmid coding virginiae butanolide; virginiamycin; BAR receptor binding proteins |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049426 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 05/23/2006 | US7049423 Nucleic acids coding fuion protein; gene expression |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049419 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 05/23/2006 | US7049416 Phosophoinositoglycan binding proteins |
| 05/23/2006 | US7049414 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 05/23/2006 | US7049413 MAGE-A3 peptides presented by HLA class II molecules |
| 05/23/2006 | US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7049410 Antibody for use in the detection of tumors |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049406 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049401 Geneteic engineered protein; isolation, purification; cloning Dna; central nervous system disorders |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049126 Human serine protease |
| 05/23/2006 | US7049125 EGVIII endoglucanase and nucleic acids encoding the same |
| 05/23/2006 | US7049112 Comprise CPRA protein (cytochrome enzyme complexes) for bioynthesis of long chain aliphatic dioic acids |
| 05/23/2006 | US7049101 Enzymes having high temperature polymerase activity and methods of use thereof |
| 05/23/2006 | US7049099 Recombinant human mannan-binding proteins and producing method of the same |
| 05/23/2006 | US7049097 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
| 05/23/2006 | US7049096 Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 |
| 05/23/2006 | US7049075 Deoxyribonuclease IIβ proteins and cDNAs |
| 05/23/2006 | US7049069 Detection of urogenital disorders in humans; obtain biological sample, monitor cytokine expression, compare to wild type control, evaluate for urogenital disorders |
| 05/23/2006 | US7049060 Secreted by hybridoma cell lines; hepatitis C virus (HCV) |
| 05/23/2006 | US7048955 Soybean phosphopeptide calcium and method for producing thereof |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048915 Composition for cell-free protein synthesis |
| 05/18/2006 | WO2006053313A2 Elaiophylin biosynthetic gene cluster |
| 05/18/2006 | WO2006053299A2 Site-directed modification of fviii |
| 05/18/2006 | WO2006053021A2 Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby |
| 05/18/2006 | WO2006052914A2 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052912A2 Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms |
| 05/18/2006 | WO2006052871A2 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052870A2 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052824A2 A mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052814A2 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052807A2 A dna molecule of mortierella alpina lpaat homolog |
| 05/18/2006 | WO2006052391A2 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 05/18/2006 | WO2006052363A2 Co-expression of multiple protein chains or subunits |
| 05/18/2006 | WO2006052016A1 METHOD OF SYNTHESIZING PROTEIN, mRNA IMMOBILIZED ON SOLID PHASE AND APPARATUS FOR SYNTHESIZING PROTEIN |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051908A1 Cell-free protein synthesizing process |
| 05/18/2006 | WO2006051901A1 Cell-free protein synthesizing process |
| 05/18/2006 | WO2006050584A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |
| 05/18/2006 | WO2005116230A3 Golgi apparatus regenerated in vitro method for production and use thereof |
| 05/18/2006 | WO2005067491A3 Toxin complex proteins and genes from xenorhabdus bovienii |
| 05/18/2006 | WO2005010170A3 Fermentation medium based on a highly hydrolized protein substrate |
| 05/18/2006 | WO2003100082A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 05/18/2006 | US20060106203 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; pharmacokinetics; surface plasmon resonance; host cell |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060105953 Polynucleotide encoding polypeptide which is protected from proteosomal degradation by cleavage of linking group; |
| 05/18/2006 | US20060105914 Plant wall degradative compounds and systems |
| 05/18/2006 | US20060105446 Biodegradable, resistant to nitrate salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 05/18/2006 | US20060105444 O-fucosyltransferase |
| 05/18/2006 | US20060105442 Promoters and proteins from Clostridium thermocellum and uses thereof |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105428 Alkaline protease |
| 05/18/2006 | US20060105427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/18/2006 | US20060105426 mcFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 05/18/2006 | US20060105425 Aspergillus niger promoter for expressing genes in host cells |
| 05/18/2006 | US20060105424 Nucleic acids which code for protein from Acremonium chrysogenum; host cells |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105417 Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof |
| 05/18/2006 | US20060105415 Method for single oxygen atom incorporation into digested peptides using peptidases |
| 05/18/2006 | US20060105413 For modulating NF- kappa B signaling |
| 05/18/2006 | US20060105389 Solubilizing inclusion bodies in a detergent to release the ScFv antibody; oxidizing to form disulfide bonds; removing the detergent;precipitating the oxidized ScFv antibodies; dissolving the precipitated ScFv antibodies in a denaturing solution; immobilizing on solid support; renaturing, elution |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105379 Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29 |
| 05/18/2006 | US20060105376 Novel full-length cDNA |
| 05/18/2006 | US20060105374 RhoB variants and methods of use |
| 05/18/2006 | US20060105371 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 05/18/2006 | US20060105364 Best's macular dystrophy gene |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105341 Trap-tagging: a novel method for the identification and purification of rna-protein complexes |
| 05/18/2006 | US20060105340 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104979 Membrane-type serine protease 1 associated with the etiology of cancer and exhibits activity in the presence of the target substrate Spectrozyme tPA |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104971 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 05/18/2006 | US20060104968 soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs); use treating glycosaminoglycan associated pathologies such as tumors or eye disorders; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104949 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | CA2587494A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 05/18/2006 | CA2587469A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | CA2586661A1 Antibodies against tenascin-c |
| 05/18/2006 | CA2586356A1 Anti-properdin antibodies, and methods for making and using same |
| 05/18/2006 | CA2585404A1 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | CA2585235A1 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | CA2584719A1 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | CA2565287A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |
| 05/17/2006 | EP1657308A1 Enhanced expression in a plant plastid |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |